logo
Fungus deadly to bats found in Colorado's Rocky Mountain National Park, crosses Continental Divide

Fungus deadly to bats found in Colorado's Rocky Mountain National Park, crosses Continental Divide

CBS News15-05-2025

A deadly fungal disease impacting bat populations has now been detected west of the Continental Divide in Colorado for the first time, raising concerns among wildlife officials. While Colorado has already identified White Nose Syndrome in Colorado in different parts of the state, the detection of the fungus Pseudogymnoascus destructans in bat guano at the Holzwarth Historic Site on the west side of the Rocky Mountain National Park adds to the growing concern for bat populations.
"It means that the fungus is continuing to spread throughout Colorado," Michelle Verant Wildlife Veterinarian with the National Parks Service, explained. "All previous cases in the state were on the eastern part... this is the first detection of the fungus West of the Continental Divide in Grand County, Colorado."
National Park Service
White-Nose Syndrome thrives in the cold temperatures where bats hibernate. The fungus grows on their skin, particularly their wings and face, causing damage that often leads to death before the bats can emerge from hibernation in the spring.
Verant explained that bats play a crucial role in maintaining healthy ecosystems, eating insects by the thousands each night, helping to control pests like mosquitoes, moths, beetles, and crickets – some of which are significant agricultural threats. According to a study, the economic impact of bats is also significant. Studies estimate that bats provide $3 billion to $22 billion each year in pest control services to North American farmers.
While WNS has caused massive population collapses on the east coast, to the tune of 90% in some cases, according to Verant, Colorado has yet to see that kind of devastation. That doesn't mean scientists are not actively monitoring Colorado bats for a crisis just like that, now that Pd is in the state. A small glimmer of hope comes from the idea that western bat species may have natural defenses against the spread of the fungus.
"Western bats tend to hibernate in more dispersed locations like rocky outcrops and crevices, unlike the large colonies found in eastern caves and mines," said Verant. This difference in hibernation habits could potentially slow the spread of the fungus, as fewer bats are bumping into each other, with a chance to spread WNS.
However, Verant cautions that in many cases, once the fungus arrives, severe disease and death follow within a few years.
Since Colorado is home to multiple bat species, each with unique behaviors, Verant said understanding how the disease affects each species is critical. Those differences could also lead to an unexpected defense. In the meantime, humanity is still working to create a solution to stop the spread of the fungus, with researchers focusing efforts on developing tools to help bats survive the disease, including antifungal compounds, environmental sprays, and even a vaccine that can boost bat immune systems.
"It's really depressing to see such a dramatic loss of these fascinating and valuable creatures," Verant said. "It will be important to continue monitoring this colony to understand if and when bats develop disease and suffer impacts from that."
If you find a dead or injured bat, do not handle it. Please report it to Colorado Parks and Wildlife at 303-291-7771 or email Wildlife.Batline@state.co.us.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SGLT2 Inhibitors May Offer Better Delirium Protection in T2D
SGLT2 Inhibitors May Offer Better Delirium Protection in T2D

Medscape

time10 hours ago

  • Medscape

SGLT2 Inhibitors May Offer Better Delirium Protection in T2D

In adults with type 2 diabetes (T2D), the use of SGLT2 inhibitors was associated with lower risks for delirium and all-cause mortality than the use of metformin, with more prominent protective effects in high-risk patients such as those aged 80 years or older. METHODOLOGY: T2D is a recognized risk factor for delirium. Although several studies have shown neuroprotective effects of metformin and cognitive protection by SGLT2 inhibitors, a real-world comparative analysis is lacking. Researchers conducted a retrospective cohort study using data from electronic health records of healthcare organizations worldwide for a head-to-head comparison of metformin and SGLT2 inhibitors in preventing delirium among patients with T2D. After propensity score matching, they included adults with T2D who initiated either SGLT2 inhibitors (n = 79,723; mean age, 65.52 years; 39.77% women) or metformin (n = 79,723; mean age, 65.62 years; 39.43% women) between January 2005 and January 2025. The primary outcome was the first recorded diagnosis of delirium, and the secondary outcome was all-cause mortality. TAKEAWAY: The use of SGLT2 inhibitors was associated with a lower risk for incident delirium than the use of metformin (adjusted hazard ratio [aHR], 0.91; 95% CI, 0.87-0.95). The risk for all-cause mortality was also reduced in patients who used SGLT2 inhibitors (aHR, 0.85; 95% CI, 0.87-0.88). The protective effect of SGLT2 inhibitors against delirium was most prominent in patients aged 80 years or older (aHR, 0.83; P < .0001), men (aHR, 0.94; P = .0131), White patients (aHR, 0.90; P < .0001), and patients with better glycemic control with A1c levels between 5% and 6.49% (aHR, 0.91; P = .0212). < .0001), men (aHR, 0.94; = .0131), White patients (aHR, 0.90; < .0001), and patients with better glycemic control with A1c levels between 5% and 6.49% (aHR, 0.91; = .0212). Among patients who used SGLT2 inhibitors, the use of medicines such as insulin, sulfonylureas, antiepileptics, and sedatives was also associated with a significantly reduced risk for delirium ( P < .05 for all). IN PRACTICE: 'By leveraging real-world data on an unprecedented scale, this study not only bridges a critical knowledge gap but also paves the way for a paradigm shift in first-line diabetes management, prioritizing both metabolic and neurocognitive health,' the study authors wrote. SOURCE: This study was led by Mingyang Sun and Xiaoling Wang, Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital in Zhengzhou, China. It was published online in Diabetes Care . LIMITATIONS: The researchers relied on diagnostic codes which may have missed milder cases of delirium, especially those managed outside hospital settings. The presence of residual confounding factors could not be completely ruled out. Information on neurocognitive markers was absent, which restricted the understanding of the neuroprotective effects of SGLT2 inhibitors. DISCLOSURES: This study was supported by grants from National Key Research and Development Program of China, National Natural Science Foundation of China, and Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital. The authors reported having no conflicts of interest.

Family Ties May Shape Hashimoto Thyroiditis Risk
Family Ties May Shape Hashimoto Thyroiditis Risk

Medscape

time10 hours ago

  • Medscape

Family Ties May Shape Hashimoto Thyroiditis Risk

The odds of developing Hashimoto thyroiditis (HT) were significantly elevated in first-, second-, and third-degree relatives of patients with HT, with female relatives having a disproportionately higher likelihood. Of note, the odds of developing HT were elevated among spouses of patients. METHODOLOGY: Relatives of patients with HT are at an increased risk for HT; however, studies have primarily focused on first-degree relatives and often employed very small sample sizes. Researchers conducted a retrospective case-control study using genealogical and medical data from a Utah-based database (1996-2021) to estimate the risk for HT in relatives across various degrees of relatedness. They included 92,405 adult HT probands (73% women; 96% White individuals) and 184,810 matched control individuals, along with 2,960,650 first-, second-, and third-degree relatives of HT probands and 5,730,159 relatives of control individuals. TAKEAWAY: Relatives of patients with HT were at an increased risk for the condition, with the highest odds observed for first-degree relatives (odds ratio [OR], 1.77; 95% CI, 1.74-1.80), followed by second-degree (OR, 1.23; 95% CI, 1.22-1.27) and third-degree (OR, 1.11; 95% CI, 1.10-1.12) relatives. The risk for HT was an additional 2.2- to 2.6-fold higher in female relatives of patients with HT than overall estimates, across all degrees of relatedness. Among first-degree relatives, sons of men with HT had a markedly elevated risk for HT (OR, 2.36; 95% CI, 2.10-2.65). Wives of men with HT and husbands of women with HT were at an increased likelihood of developing HT, suggesting the effect of a shared environment. IN PRACTICE: 'These findings also have clinical implications, as understanding familial clustering of HT can help healthcare providers identify individuals at higher risk, especially those with affected FDRs [first-degree relatives]. This knowledge could lead to earlier monitoring and intervention, improving disease management,' the authors of the study wrote. SOURCE: This study was led by Melissa Bujnis, PhD, Department of Human Genetics, University of Utah, Salt Lake City. It was published online in The Journal of Clinical Endocrinology & Metabolism . LIMITATIONS: Reliance on diagnostic codes may have introduced misclassification bias, particularly in cases of transient hypothyroidism or misdiagnosed HT. Variations in diagnostic practices across clinics may have introduced heterogeneity in the sample. Individuals with a family history of HT might be more likely to receive diagnosis or seek medical attention, potentially introducing ascertainment bias. DISCLOSURES: Partial support for the datasets in the database was provided by the University of Utah, Huntsman Cancer Institute, National Institutes of Health (NIH). This study received support from NIH, NCRR, and Utah Department of Health and Human Services and the University of Utah. The authors reported no relevant conflicts of interest.

North America Hair Care Market, Competition, and Forecasts 2025-2030: Rise of Scalp Care and Skinification of Hair
North America Hair Care Market, Competition, and Forecasts 2025-2030: Rise of Scalp Care and Skinification of Hair

Yahoo

time10 hours ago

  • Yahoo

North America Hair Care Market, Competition, and Forecasts 2025-2030: Rise of Scalp Care and Skinification of Hair

The North America Hair Care Market is poised for growth by focusing on personalized, natural products and eco-conscious solutions. Increased consumer awareness of hair health, bolstered by social media influence and e-commerce accessibility, offers opportunities in clean, innovative formulations despite market saturation challenges. North American Hair Care Market Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "North America Hair Care Market, By Country, Competition, Forecast and Opportunities, 2020-2030F" has been added to North America Hair Care Market was valued at USD 23.67 Billion in 2024, and is expected to reach USD 40.01 Billion by 2030, rising at a CAGR of 9.16%. Growth in this market is supported by increased awareness of hair health, rising demand for personalized and natural products, and a stronger focus on personal grooming. Consumers are seeking solutions that cater to specific hair needs influenced by factors such as lifestyle and environmental exposure. In response, brands are introducing advanced formulations with clean labels, sustainable packaging, and eco-conscious ingredients. Social media trends and celebrity endorsements continue to influence consumer behavior, with 46% of U.S. consumers reportedly increasing their beauty product spending due to social media in 2023. Additionally, the expansion of e-commerce has made premium and salon-quality hair care products more accessible, driving further market penetration across the region. Key Market Drivers: Rising Consumer Awareness and Focus on Hair Health An increasing focus on hair health and hygiene is a major driver of the North America hair care market. Consumers are shifting from basic cleansing and styling products toward solutions that offer added health benefits, such as strengthening, anti-hair fall, scalp care, and growth stimulation. Data from Advanced Dermatology shows that Americans spend around USD 897 annually on personal appearance, including an average of USD 277 on haircuts. This investment in grooming underscores the consumer priority for high-quality hair care. The trend is further fueled by digital platforms where influencers, dermatologists, and brands share educational content, reviews, and product insights. Consumers are also more informed about the effects of stress, diet, and environmental pollutants on hair, prompting demand for clean, sulfate- and paraben-free formulations. As a result, brands are developing dermatologist-tested and ingredient-transparent products to meet evolving health-conscious needs, contributing to robust market expansion. Key Market Challenges: High Market Saturation and Intense Competition The North American hair care market is marked by intense competition and high saturation. Major players such as L'Oreal, Procter & Gamble, Unilever, and Johnson & Johnson dominate the space with extensive product lines, established brand loyalty, and large-scale distribution. Simultaneously, niche and digitally native brands are entering the market, offering unique products aimed at specific needs such as clean beauty or textured hair care. This saturation creates challenges for new entrants to gain visibility and for existing players to sustain customer loyalty. Companies are compelled to invest heavily in R&D, digital marketing, and continuous innovation to remain competitive. Price wars and promotional tactics further impact profit margins, particularly for smaller brands. In such a crowded marketplace, achieving differentiation and long-term viability poses a significant hurdle. Key Market Trends: Rise of Scalp Care and Skinification of Hair A notable trend in the North America hair care market is the growing emphasis on scalp care, a movement often referred to as the "skinification" of hair. Consumers are increasingly treating the scalp with the same care and attention as facial skin, seeking ingredients and product formats commonly associated with skincare. This includes scalp exfoliants, detox treatments, hydrating serums, and microbiome-balancing solutions. Popular skincare ingredients like salicylic acid, niacinamide, hyaluronic acid, and ceramides are now integrated into shampoos and conditioners to address concerns such as dryness, oil imbalance, and inflammation. Personalized scalp diagnostics, available both online and in salons, are also helping consumers select tailored hair care routines. This trend reflects a broader shift toward precise, skincare-inspired hair routines, and continues to drive innovation and product development across the category. Key Market Players: Kanebo Cosmetics Inc. Unilever plc Johnson & Johnson Services, Inc. Shiseido Americas Corporation The Estee Lauder Companies Inc L'Oreal S.A. Beiersdorf, Inc. Amorepacific Corporation Revlon Inc. Kao USA Inc. Report Scope: In this report, the North America Hair Care Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: North America Hair Care Market, By Product Type: Hair Spray Conditioner Shampoo Hair Oil Others North America Hair Care Market, By Sales Channel: Hypermarket/Supermarket Departmental Stores Specialty Stores Online Others North America Hair Care Market, By Country: United States Canada Mexico Key Attributes: Report Attribute Details No. of Pages 131 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $23.67 Billion Forecasted Market Value (USD) by 2030 $40.01 Billion Compound Annual Growth Rate 9.1% Regions Covered North America For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment North American Hair Care Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store